Akm Monwarul Islam

Current Trends and Future Perspectives in the Treatment of Pulmonary Hypertension: WHO Group II-V

Pulmonary hypertension continues to be a life-threatening illness with debilitating physical and emotional consequences affecting around 1% of global population. The progression of this devastating disease is characterized by increase in pulmonary vascular resistance resulting in elevated pulmonary pressure, eventually leading to right heart failure and death. Better understanding of pathophysiology has led to substantial improvements in terms of availability of treatment options. The purpose of this review is to summarize the currently available treatment options along with pertinent trials and possible future therapies of pulmonary hypertension group II-V.

Rheumatic Fever and Rheumatic Heart Diseases in Bangladesh: Challenges and Remedies

In the 21 st century, Rheumatic fever (RF) and Rheumatic heart disease (RHD) are neglected diseases of marginalized communities. Globally, RHD remains the most-common cardiovascular disease in young people aged <25 years. Although RF and RHD have been almost eradicated in areas with established economies, migration from low-income to high-income settings might be responsible for a new burden of RHD in high-income countries. Globally, the prevalence of rheumatic fever (RF) and rheumatic heart disease (RHD) has declined sharply but, in developing countries, RF is still aleading cause of heart disease and, consequently, death in children and young adults. In 2005, it was estimated that over 2.4 million children aged 5-14 years were having RHD globally and 79% of all these cases were from lessdeveloped countries. Cardiovasc. j. 2018; 10(2): 206-211

TCTAP A-182 Immediate In-Hospital Complications of Percutaneous Transvenous Mitral Commissurotomy in Patients with Mitral Stenosis

Rheumatic fever and rheumatic heart disease continue to be the major health problem in all developing countries including Bangladesh. Rheumatic mitral stenosis is a very common problem in our population having an incidence of 54 percent among rheumatic heart disease with a female preponderance of 2:

Percutaneous Coronary Intervention in Left Main Coronary Artery Disease - A Case Report

Not available DOI: http://dx.doi.org/10.3329/uhj.v8i1.11669 University Heart Journal Vol. 8, No. 1, January 2012